Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

JAK inhibitors might help treat alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Treatment with prednisolone and dapsone stopped new blisters and partially healed previous ones.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

The patch effectively promotes hair growth for alopecia areata without pain.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.